JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M112149200 on February 11, 2002

J. Biol. Chem., Vol. 277, Issue 16, 13473-13478, April 19, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/16/13473    most recent
M112149200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barabé, F.
Right arrow Articles by Naccache, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barabé, F.
Right arrow Articles by Naccache, P. H.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cholesterol-modulating Agents Selectively Inhibit Calcium Influx Induced by Chemoattractants in Human Neutrophils*

Frédéric BarabéDagger , Guillaume ParéDagger , Maria J. G. FernandesDagger , Sylvain G. Bourgoin§, and Paul H. NaccacheDagger

From the Dagger  Canadian Institutes for Health Research group on the Molecular Mechanisms of Inflammation, Centre de Recherche en Rhumatologie et Immunologie, Centre de Recherche du CHUL, Departments of Medicine and § Physiology, Laval University, Québec, G1V 4G2 Canada

Received for publication, December 19, 2001, and in revised form, February 5, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The effects of cholesterol-perturbing agents on the mobilization of calcium induced upon the stimulation of human neutrophils by chemotactic factors were tested. Methyl-beta -cyclodextrin and filipin did not alter the initial peak of calcium mobilization but shortened the duration of the calcium spike that followed the addition of fMet-Leu-Phe. These agents also inhibited the influx of Mn2+ induced by fMet-Leu-Phe or thapsigargin. Methyl-beta -cyclodextrin and filipin completely abrogated the mobilization of calcium induced by 10-10 M platelet-activating factor, which at this concentration depends to a major extent on an influx of calcium as well as the influx of calcium induced by 10-7 M platelet-activating factor. On the other hand, methyl-beta -cyclodextrin and filipin enhanced the mobilization of calcium induced by ligation of Fcgamma RIIA, an agonist that did not induce a detectable influx of calcium. Finally, methyl-beta -cyclodextrin and filipin enhanced the stimulation of the profile of tyrosine phosphorylation, the activity of phospholipase D (PLD), and the production of superoxide anions induced by fMet-Leu-Phe. These results suggest that the calcium channels utilized by chemotactic factors in human neutrophils are either located in cholesterol-rich regions of the plasma membrane, or that the mechanisms that lead to their opening depend on the integrity of these microdomains.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The migration of human polymorphonuclear leukocytes (neutrophils) to sites of infection or tissue injury is an essential element of their role in the first line of immune defense. It is orchestrated by the local accumulation of chemotactic factors that may be of endogenous or exogenous origin. Examples of the former include complement-derived factors (e.g. C5a), lipid-derived mediators such as leukotriene B4 and platelet-activating factor (PAF),1 and tissue-derived chemokines (interleukin-8 (IL-8) in particular). Small formylated peptides of which fMet-Leu-Phe is the archetypical member represent examples of bacterially derived products known to attract neutrophils (1).

Most neutrophil chemotactic factors including those named above interact with plasma membrane receptors that belong to the superfamily of G protein-coupled receptors (2-4). Their occupancy results in the G protein-dependent activation of several signaling pathways (PLCbeta , adenylate cyclase, tyrosine phosphorylation) that lead to the generation of multiple second messengers including transient increases in the level of cytoplasmic free calcium (5, 6). These are known to be involved in the initiation and modulation of several critical neutrophil responses including phagocytosis (7-9) and the activation of the NADPH oxidase (10-12).

The increases in the level of free cytoplasmic calcium induced by chemotactic factors result from the intracellular release of calcium mediated by PLCbeta -derived inositol 3,4,5-trisphosphate coupled in a poorly understood manner to an increased influx of calcium from the extracellular medium (13, 14). Although the identity of the calcium channels responsible for the influx of calcium in nonexcitable cells is still under investigation (15, 16), recent data has implicated one or more homologs of Drosophila Trp (transient receptor potential) protein in this process (16-19), some of which may partition into lipid raft domains (20). A role for cyclic ADP-ribose in the regulation of the influx of calcium has also been postulated (21).

The present study was initiated to investigate the potential involvement of cholesterol-rich membrane microdomains in the modulation of the mobilization of calcium induced by chemotactic factors in human neutrophils. The results to be described provide evidence that agents that interfere with plasma membrane cholesterol selectively inhibit the chemoattractant-stimulated influx of calcium without altering the release of calcium from intracellular stores. These results suggest that the calcium channels activated by these agonists are either located in cholesterol-rich membrane microdomains or that the mechanisms that couple intracellular store depletion to their activation are dependent on the integrity of the microdomains.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Reagents and Antibodies-- Methyl-beta -cyclodextrin (Mbeta CD), Filipin III, thapsigargin, and fMLP were purchased from Sigma. Fura-2/AM and Fluo-3/AM were obtained from Molecular Probes. PAF was kindly provided by Dr. Pierre Borgeat (Laval University, Québec, Canada).

The anti-Fcgamma RIIA monoclonal antibody IV.3 was purified from the ascites of mice inoculated with hybridoma HB 217 obtained from the American Type Culture Collection. The anti-phosphotyrosine antibody 4G10 was purchased from Upstate Biotechnology. The goat F(ab')2 fragments directed against mouse F(ab')2 used for cross-linking were purchased from Jackson ImmunoResearch Laboratories. F(ab')2 fragments of antibody IV.3 were prepared essentially as described in the Pierce catalog.

Neutrophil Purification-- Venous blood was collected in isocitrate anticoagulant from healthy adult volunteers, and neutrophils were sterilely purified as previously described (22). Neutrophils at 1 × 107 cells/ml were resuspended in Hanks' balanced salt solution (HBSS) containing 1.6 mM CaCl2 but no magnesium.

Measurement of Cytoplasmic Free Calcium Concentration-- Neutrophils (1 × 107/ml) were incubated at 37 °C for 30 min with 10 mM Mbeta CD, 0.5 µg/ml filipin or their solvent (Me2SO and ethanol, respectively), and with 1 µM Fura-2/AM or 1 µM Fluo-3/AM. The cells were washed and resuspended at 5 × 106 cells/ml in HBSS with 1.6 mM CaCl2. Neutrophils were then kept at 37 °C and transferred to the thermostatted cuvette compartment of a spectrofluorimeter (SLM 8000C). Neutrophils were stimulated with the indicated agonists at the times indicated by the arrows in the individual figures. In the case of stimulation of Fcgamma RIIA, the cell suspensions were incubated for 2 min with antibody IV.3 (2.5 µg/ml of F(ab')2 fragments), and Fcgamma RIIA was then cross-linked upon the addition of 25 µg/ml of goat F(ab')2 fragments against mouse F(ab')2. The fluorescence of the cells was monitored at an excitation wavelength of 340 nm and an emission wavelength of 510 nm for the Fura-2 probe. In the experiments where Fluo-3 was used, the wavelengths used for excitation and emission were 506 and 526 nm, respectively. The internal calcium concentrations were calculated as described by Grynkievicz et al. (23).

Manganese Influx Measurement-- Neutrophils were preincubated as described above with Mbeta CD, filipin, or their diluents and with 1 µM Fura-2/AM. The cells were washed and resuspended in HBSS without calcium and magnesium. The wavelengths used for these experiments were 360 and 505 nm for excitation and emission, respectively. After 10 s, 200 µM MnCl2 was added to the cell suspensions that were then stimulated with the indicated agonists at 75 s. Adenosine deaminase (0.1 units/ml) was added 5 min before MnCl2 in those experiments in which the effects of thapsigargin were monitored. Manganese influx is reported in arbitrary fluorescence units.

Tyrosine Phosphorylation-- Neutrophils, at 1 × 107 cells/ml, were incubated with Mbeta CD, filipin, or their solvents as described above. The cells were washed and stimulated with fMLP (10-7 M) at 37 °C for the indicated times. The reactions were stopped by transferring 100 µl of the cell suspensions to an equal volume of boiling 2× Laemmli sample buffer (1× is 62.5 mM Tris-HCl, pH 6.8, 4% SDS, 5% beta -mercaptoethanol, 8.5% glycerol, 2.5 mM orthovanadate, 10 mM paranitrophenylphosphate, 10 µg/ml leupeptin, 10 µg/ml aprotinin, 0.025% bromphenol blue) and boiled for 7 min. The samples were then subjected to 7.5-20% SDS-PAGE gradients and transferred to immobilon polyvinylidene difluoride membranes (Millipore). Immonoblotting was performed using the 4G10 antiphosphotyrosine antibody (final dilution 1:4000) and revealed using the ECL detection system as previously described (24).

Phospholipase D Measurements-- Neutrophils were prelabeled with 1-O-[3H]alkyl-2-lyso-phosphatidylcholine (2 µCi/107 cells) for 90 min as described previously (25-27). For the last 30 min, 10 mM Mbeta CD were added to the cells. Neutrophils were then washed and resuspended at 8 × 106 cells/ml. Ethanol (final concentration, 1.0% v/v) was added immediately preceding the addition of fMLP (10-7 mol/liter, 10 min). The incubations were stopped by adding 1.8 ml of cold chloroform/methanol/HCl (50:100:1, v/v/v) and unlabeled phosphatidylethanol (PEt) as a standard. The lipids were extracted, dried under nitrogen, and spotted on prewashed silica gel 60 thin-layer chromatographic (TLC) plates. PEt was separated from the other lipids with the solvent mixture chloroform/methanol/acetic acid (65:15:2, v/v/v). Lipids were visualized by Coomassie Brilliant Blue staining, and the different lipid classes were scraped off the plates. Radioactivity in PEt was monitored by liquid scintillation counting, and the results were corrected for background radioactivity and quenching.

Superoxide Measurements-- Superoxide production was measured using the reduction of cytochrome c as previously described (28). Briefly, the cells were resuspended at 106 cells/ml with 130 µM cytochrome c and stimulated for 5 min at 37 °C with fMet-Leu-Phe. The tubes were then transferred to an ice bucket for 15 min and centrifuged for 10 min at 1,500 × g. The optical density of the supernatants was read at 540 and 550 nm, and the amounts of superoxide produced were calculated from the differences between the optical readings at 550 nm and those at 540 nm using an extinction coefficient of 21.1.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Effects of Methyl-beta -cyclodextrin on the Mobilization of Calcium Induced by fMet-Leu-Phe-- As previously reported (6) the addition of 10-7 M fMet-Leu-Phe to a suspension of human neutrophils led to increases in the concentration of cytoplasmic free calcium as monitored using the fluorescent calcium probe Fura-2 (Fig. 1). This increase was rapid and transient with levels of cytosolic free calcium returning to near basal values by 2-3 min poststimulation. Pretreating the cells with 10 mM Mbeta CD, a cholesterol-binding agent, had little effect on the peak of calcium mobilization induced by fMet-Leu-Phe. In contrast, it significantly reduced the duration of the calcium spike affecting mostly the maintenance of the elevated calcium levels (Fig. 1A). The concentrations of Mbeta CD used were similar to those that had previously been characterized in other cell types as effective in reducing plasma membrane cholesterol levels with minimal overall cell damage (29-32). Mbeta CD did not affect cell viability under the experimental conditions used as evidenced by trypan blue exclusion (data not shown), the maintenance of normal levels of resting cytoplasmic calcium, and the ability to respond to fMet-Leu-Phe (initial phase of calcium mobilization, superoxide production, activation of PLD, tyrosine phosphorylation (see Fig. 7)). A second agent affecting cholesterol-rich membranes, the cholesterol-sequestering antibiotic (33, 34) filipin, was tested to corroborate the results obtained with Mbeta CD using Fluo-3 as a probe to circumvent optical interferences between Fura-2 and filipin. The results shown in Fig. 1B indicate that filipin had no effect on the early peak of cytoplasmic free calcium induced by fMet-Leu-Phe, but it reduced the duration of the maintenance of the elevation of cytoplasmic free calcium much as Mbeta CD did (Fig. 1A).


View larger version (15K):
[in this window]
[in a new window]
  		Fig. 1.   Effect of Mbeta CD and filipin on the mobilization of calcium induced by fMet-Leu-Phe. The cells were preincubated with Mbeta CD (10 mM) or with filipin (0.5 µg/ml) during the Fura-2/AM (Mbeta CD) or Fluo-3 (Filipin) loading period. Following the washing step fMet-Leu-Phe was added, and the mobilization of calcium was monitored. The results are from separate experiments, each carried out in duplicates on three or more donors.

The modifications to the shape of the calcium spike brought about by pretreatment with Mbeta CD and filipin suggested that these compounds were acting principally on the influx of calcium that follows the depletion of intracellular calcium stores induced upon activation of chemotactic factor receptors. Two sets of experiments were carried out to test this hypothesis as directly as possible.

First, calcium influx was monitored by following the quenching of intracellular Fura-2 that results from the entry of Mn2+ through the calcium channels (35, 36). The results of these studies are illustrated in Fig. 2. As expected, the addition of fMet-Leu-Phe to a suspension of neutrophils loaded with Fura-2 increased within about 30 s, the rate of quenching of the calcium probe. This effect is a reflection of the increased plasma membrane permeability to divalent cations (increased calcium influx). Of particular relevance to the present study is the practically complete inhibition of the fMet-Leu-Phe-induced increased rate of quenching of Fura-2 that is observed following pretreatment with Mbeta CD (panel A) and filipin (panel B), effects that are indicative of an inhibition of the opening of the calcium channels.


View larger version (14K):
[in this window]
[in a new window]
  		Fig. 2.   Effect of Mbeta CD and filipin on the influx of Mn2+ stimulated by fMet-Leu-Phe. Mn2+ influx, monitored by the quenching of intracellular Fura-2, was measured as described under "Materials and Methods." The incubation conditions for Mbeta CD (A) and filipin (B) were as described in the legend to Fig. 1. The results are from separate experiments, each carried out in duplicate on cells from three or more donors.

Second, the mobilization of calcium induced by fMet-Leu-Phe was monitored immediately following chelation of extracellular calcium by EGTA. Under those conditions of low extracellular calcium most if not all of the increases in the levels of cytosolic free calcium can be assumed to be derived from the emptying of the intracellular stores of calcium. As shown in Fig. 3 the addition of 2 mM EGTA to the cells prior to stimulation with fMet-Leu-Phe significantly reduced the maintenance of the elevated calcium levels without significantly affecting the initial peak of mobilization of calcium. These modifications in the pattern of cytoplasmic free calcium mobilization induced by the addition of EGTA are similar to those induced by Mbeta CD. It is also important to point out that adding EGTA to Mbeta CD-treated cells was without any significant additional effect on the mobilization of calcium induced by fMet-Leu-Phe (compare the Mbeta CD tracing to that of Mbeta CD+EGTA).


View larger version (19K):
[in this window]
[in a new window]
  		Fig. 3.   Effect of Mbeta CD on the mobilization of calcium induced by fMet-Leu-Phe in the presence of extracellular EGTA. Neutrophils, preincubated or not with Mbeta CD (as described in the Fig. 1 legend), were stimulated with fMet-Leu-Phe in the absence or presence of 2 mM EGTA (added 30 s before fMet-Leu-Phe). The results are from a single experiment representative of duplicate determinations on cells from three or more donors.

Effects of Methyl-beta -cyclodextrin on the Mobilization of Calcium Induced by PAF-- Having observed that the influx of calcium induced by fMet-Leu-Phe was inhibited in Mbeta CD-treated cells, we next examined the effects of this agent on neutrophil agonists that either were very dependent on an influx of calcium or, alternatively, did not rely to a significant extent on this response.

Previous studies provide evidence that the mobilization of calcium induced by low concentrations of the lipid mediator PAF differs from that stimulated by fMet-Leu-Phe in that it was nearly completely dependent on an influx of calcium from the extracellular medium (37, 38). Neutrophils were therefore pretreated with Mbeta CD, loaded with Fura-2, and treated with 10-10 M PAF. As shown in Fig. 4A, PAF at this concentration was still able to significantly increase the level of cytoplasmic free calcium. Mbeta CD completely inhibited the mobilization of calcium induced by 10-10 M PAF. The data in panel B show that the influx of calcium induced by 10-10 M PAF was completely inhibited by Mbeta CD.


View larger version (19K):
[in this window]
[in a new window]
  		Fig. 4.   Effect of Mbeta CD on the mobilization of calcium and the influx of Mn2+ induced by PAF. The incubation conditions with Mbeta CD were as in Fig. 1. The cells were stimulated with 10-10 M (panels A and B) or 10-7 M (panels C and D) PAF. The results are from separate experiments, each carried out in duplicate on cells from three or more donors.

At higher concentrations the mobilization of calcium induced by PAF closely resembles that of other chemoattractants, i.e. an immediate spike due to a release of intracellular calcium followed by a wave of calcium derived from the extracellular medium. Mbeta CD treatment inhibited the second phase of calcium mobilization induced by 10-7 M PAF (Fig. 4C) much as it had that induced by fMet-Leu-Phe (Fig. 1). The influx of calcium induced by 10-7 M PAF was inhibited by Mbeta CD (panel D) as was observed at low concentrations of PAF (panel B).

Effects of Methyl-beta -cyclodextrin on the Mobilization of Calcium Induced by Ligation of Fcgamma RIIA-- The mobilization of calcium induced by the Fcgamma IIA in contrast to that induced by chemotactic factors (e.g. Fig. 1) is not coupled to an influx of calcium and relies to a much larger extent on the recruitment of calcium from intracellular stores.

Cross-linking of Fcgamma RIIA induced a rapid and transient mobilization of calcium (Fig. 5, panel A) that was not inhibited by Mbeta CD. The extent of the mobilization of calcium induced by ligation of Fcgamma RIIA was relatively unaffected by the addition of EGTA (data not shown), and no evidence for increased Mn2+-dependent quenching of Fura-2 was obtained (Fig. 6B) indicating that most if not all of the calcium was derived from intracellular stores. It should be noted that these experiments did not address the question of the nature of the calcium stores called upon by these receptors and their relationship to those mobilized by chemotactic factors.


View larger version (16K):
[in this window]
[in a new window]
  		Fig. 5.   Effect of Mbeta CD on the mobilization of calcium and the influx of Mn2+ induced by ligation of Fcgamma RIIA. The incubation conditions with Mbeta CD were as described in the legend to Fig. 1. Details of the Fcgamma RIIA ligation procedure are described under "Materials and Methods." The results in the two panels are from separate experiments, each carried out in duplicate on cells from three or more donors.


View larger version (13K):
[in this window]
[in a new window]
  		Fig. 6.   Effect of Mbeta CD and filipin on the influx of Mn2+ induced by thapsigargin. The incubation conditions with Mbeta CD and filipin were as in Fig. 1. Thapsigargin was added at the time indicated by the dotted arrow. The results are from a single experiment, representative of duplicate determinations on cells from three or more donors.

Effects of Cholesterol-modulating Agents on the Influx of Calcium Induced by Thapsigargin-- One of the strongest pieces of evidence for the presence of store-operated calcium (SOC) channels in cells is provided by the ability of the Ca2+-ATPase inhibitor thapsigargin to stimulate an influx of Mn2+ subsequent to the depletion of intracellular calcium stores (39, 40). As shown in Fig. 6 this effect is readily detectable in neutrophils as evidenced by the increased rate of Mn2+-dependent quenching of Fura-2 following the addition of thapsigargin. Pretreatment with Mbeta CD or filipin nearly abolished the stimulation of the influx of Mn2+ induced by thapsigargin.

Effects of Methyl-beta -cyclodextrin on the Tyrosine Phosphorylation, Phospholipase D Activation, and Oxidative Responses to fMet-Leu-Phe-- The effects of Mbeta CD on other neutrophil responses to fMet-Leu-Phe were tested next. As shown in Fig. 7A, Mbeta CD enhanced the stimulation of the pattern of tyrosine phosphorylation elicited by the chemotactic factor at all time points tested, and this effect was also observed with the cholesterol-sequestering agent filipin (data not shown). The enhancing effects of Mbeta CD and filipin on the levels of tyrosine phosphorylation were not reproduced by inhibiting the influx of calcium with EGTA (data not shown) indicating that the former did not result from the inhibition of the entry of calcium per se. Increases in the pattern of tyrosine phosphorylation were also observed in Mbeta CD-treated cells stimulated with 10-7 M PAF (data not shown). Mbeta CD had a similar stimulatory effect on the enhancement of the activity of phospholipase D (Fig. 7B) and the activation of the oxidative burst (Fig. 7C) induced by fMet-Leu-Phe.


View larger version (18K):
[in this window]
[in a new window]
  		Fig. 7.   Effect of Mbeta CD on various responses of human neutrophils to fMet-Leu-Phe. The ability of fMet-Leu-Phe to stimulate the tyrosine phosphorylation (panel A) activity of PLD (panel B) and the production of superoxide anions (panel C) in cells preincubated, or not, with Mbeta CD was monitored. The procedures are detailed under "Materials and Methods." Asterisk, statistically different from the values of the fMet-Leu-Phe samples (p < 0.05, Wilcoxon matched pairs test).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The results of the present investigation provide evidence for a role for cholesterol-rich membrane microdomains in the link between the emptying of intracellular calcium stores and the opening of the calcium channels as stimulated by G protein-coupled receptors in human neutrophils.

The cholesterol-modifying depleting agents Mbeta CD and filipin inhibited the stimulation of the influx of calcium induced by fMet-Leu-Phe and PAF. The receptors of these chemoattractants belong to the superfamily of G protein-coupled receptors (4). They are thought to share many of the steps leading to the mobilization of calcium including reliance on the same intracellular stores of calcium and, although this had not been directly established, the same mechanisms of coupling to the plasma membrane calcium channels or SOCs (capacitative calcium entry). The common sensitivity of the calcium influx stimulated by these agonists to inhibition by Mbeta CD and filipin is consistent with this view.

Several lines of evidence indicate that the effects of Mbeta CD and filipin are not due to a general deleterious effect on cell viability. First, no differences in trypan blue exclusion were noted between treated and untreated cells under the conditions reported here (data not shown). Second, neither agent significantly altered the resting levels of cytoplasmic calcium, a sensitive indicator of cell integrity. Third, the initial mobilization of calcium induced by fMet-Leu-Phe was not affected by these agents indicating that the steps leading to the Ins(3,4,5)P3-mediated release of calcium, including the integrity of the calcium stores, were intact. Fourth, the effects of Mbeta CD and of filipin were limited to interference with the mobilization of calcium as several neutrophil responses (tyrosine phosphorylation, O<UP><SUB>2</SUB><SUP>−</SUP></UP> generation, activation of PLD) were not inhibited but in fact were enhanced. Finally, the mobilization of calcium induced by the cross-linking of Fcgamma RIIA was also enhanced. Taken together, these data provide strong evidence for a selective and nontoxic effect of cholesterol-modulating agents on the responses of human neutrophils to the activation of chemotactic factor receptors under the experimental conditions tested here.

The effects of Mbeta CD and filipin resided primarily at the level of the activation of the SOCs. Evidence for this conclusion comes most specifically from the following: (i) the lack of effect on the magnitude of the initial spike of calcium mobilization, an indicator of calcium release from intracellular stores, (ii) the lack of effect of Mbeta CD on the mobilization of calcium observed in the absence of extracellular calcium, and (iii) the inhibition of the uptake of Mn2+, a classic index of inward-directed calcium permeability, and in particular following the addition of the Ca2+-ATPase inhibitor thapsigargin. It is consistent with the sensitivity of the mobilization of calcium induced by low concentrations of PAF to Mbeta CD, concentrations at which the lipid mediator relies to a major extent on increases in plasma membrane permeability to calcium and only marginally on release from intracellular stores (37, 38). Finally, the relative resistance of the calcium mobilization induced by ligation of Fcgamma RIIA to the cholesterol-perturbing agents also supports this conclusion as the activation of the latter receptor does not appear to be tightly coupled to increases in calcium influx. This may be related to the possible utilization of different pools of intracellular calcium by chemotactic factor and opsonin receptors (42). Finally, the present results differ from the previously described interference with calcium signaling through the Fc receptor in RBL cells by cholesterol-depleting agents (43) indicating that the DRM dependence of the various Fc receptors vary as a function of cell or receptor type. In addition, they are unlikely to be explained by direct interference with the partitioning of G protein subunits in DRMs such as has been described for Gq/11 (44), because this would have resulted in the inhibition of all responses to fMet-Leu-Phe and PAF. On the other hand, they are consistent with the results of Petrie et al. (31) who observed that although cholesterol sequestration disrupted lipid rafts in B cells and prevented B cell receptor (BCR) redistribution, it did not inhibit tyrosine kinase activation or phosphorylation of extracellular regulated kinase. The effects of Mbeta CD and filipin on the calcium response to cross-linking of Fcgamma RIIA also resemble those of Petrie et al. (31) who observed that raft disruption enhanced the release of calcium from intracellular stores following BCR stimulation.

The results presented are consistent with the interpretation that the link between the emptying of the Ins(3,4,5)P3-sensitive stores and subsequent opening of plasma membrane calcium (capacitative calcium entry) is dependent on the integrity of the plasma membrane microdomains rich in cholesterol. These are known by various names including detergent insoluble glycolipid enriched membrane fractions (DIGs), DRMs, and lipid rafts, a multiplicity that may reflect subpopulations of these microdomains (45) that are thought to act as hubs of concentration of signaling molecules. Their involvement in the regulation of calcium channels in human neutrophils is to the best of our knowledge undocumented. However, these results are consistent with the recent identification of hTrp1, a putative component of SOCs, in the low density fraction of Triton X-100-extracted human submandibular gland cell membranes (20), which is an empirical definition of DRMs. It should be noted however, that the present data do not allow us to distinguish between the possibilities that SOCs are themselves located within the cholesterol-rich microdomains or whether a necessary intermediary step between the emptying of the intracellular calcium stores and the opening of the calcium channels depends on the integrity of these microdomains. The very recent observations that the calcium influx induced by fMet-Leu-Phe was inhibited in CD38- neutrophils (46) and that CD38 was associated with lipid rafts in T lymphocytes (47) raise the intriguing possibility of a relationship between CD38 and our results.

Finally, although this study focused on the effects of cholesterol-perturbing agents on the mobilization of calcium, it also uncovered an unexpected up-regulation of several neutrophil responses upon the addition of either Mbeta CD or filipin. The three responses examined, tyrosine phosphorylation, activation of PLD, and production of superoxide anions are experimentally independent but may be causally related. Indeed, the activation of PLD is thought to be controlled by one or more tyrosine phosphorylation-dependent steps (48), and several lines of investigation indicate that the production of superoxide anions lies downstream from the activation of PLD (49). It is therefore conceivable that the enhancements of the stimulation of the activity of PLD (several isozymes of which have been localized to DRMs, Refs. 41, 50, 51) and of the production of superoxide anions are secondary to that of the profile of tyrosine phosphorylation. A corollary of this interpretation is that components of cholesterol-rich microdomains (tyrosine phosphatases?) may act to limit the extent of the activation of human neutrophils by chemotactic factors.

    FOOTNOTES

* This work was supported in part by grants from the Canadian Institutes for Health Research and the Arthritis Society of Canada.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: CHUL, Rm. T1-49 2705 Boulevard Laurier Sainte-Foy, Québec, G1V 4G2, Canada. Tel.: 418-654-2772; Fax: 418-654-2765; E-mail: paul.naccache@crchul. ulaval.ca.

Published, JBC Papers in Press, February 11, 2002, DOI 10.1074/jbc.M112149200

    ABBREVIATIONS

The abbreviations used are: PAF, platelet-activating factor; Mbeta CD, methyl-beta -cyclodextrin; PL, phospholipase; SOC, store-operated calcium; AM, acetoxymethyl ester; Ins(3, 4,5)P3, inositol 3,4,5-trisphosphate; fMLP, formylmethionylleucylphenylalanine; DRM, detergent-resistant membranes.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Marasco, W. A., Phan, S. H., Krutzsch, H., Showell, H. J., Feltner, D. E., Nairn, R., Becker, E. L., and Ward, P. A. (1984) J. Biol. Chem. 259, 5430-5440[Abstract/Free Full Text]
2. Murphy, P. M. (1997) Semin. Hematol. 34, 311-318[Medline] [Order article via Infotrieve]
3. Prossnitz, E. R., and Ye, R. D. (1997) Pharmacol. Ther. 74, 73-102[CrossRef][Medline] [Order article via Infotrieve]
4. Gerard, C., and Gerard, N. (1997) Curr. Opin. Immunol. 6, 140-145
5. Petroski, R. J., Naccache, P. H., Becker, E. L., and Sha'afi, R. I. (1979) Am. J. Physiol. 237, C43-49[Medline] [Order article via Infotrieve]
6. White, J. R., Naccache, P. H., Molski, T. F. P., Borgeat, P., and Sha'afi, R. I. (1983) Biochem. Biophys. Res. Commun. 113, 44-50[CrossRef][Medline] [Order article via Infotrieve]
7. Edberg, J., Lin, C., Lau, D., Unkeless, J., and Kimberly, R. (1995) J. Biol. Chem. 270, 22301-22307[Abstract/Free Full Text]
8. Fallman, M., Lew, D. P., and Andersson, T. (1989) J. Clin. Invest. 84, 886-891[Medline] [Order article via Infotrieve]
9. Stendahl, O., Krause, K. H., Krischer, J., Jerstrom, P., Theler, J., Clark, R. A., Carpentier, J. L., and Lew, D. P. (1994) Science 265, 1439-1441[Abstract/Free Full Text]
10. Meshulam, T., Diamond, R. D., Lyman, C. A., Wysong, D. R., and Melnick, D. A. (1988) Biochem. Biophys. Res. Commun. 150, 532-539[CrossRef][Medline] [Order article via Infotrieve]
11. Robinson, J. M., Badwey, J. A., Karnovsky, M. L., and Karnovsky, M. J. (1984) Biochem. Biophys. Res. Commun. 122, 734-739[CrossRef][Medline] [Order article via Infotrieve]
12. Smolen, J. E., Korchak, H. M., and Weissmann, G. (1981) Biochim. Biophys. Acta 677, 512-520[Medline] [Order article via Infotrieve]
13. Putney, J. W., Broad, L. M., Braun, F. J., Lievremont, J. P., and Bird, G. S. J. (2001) J. Cell Sci. 114, 2223-2229[Medline] [Order article via Infotrieve]
14. Berridge, M. (1984) Biochem. J. 220, 345-360[Medline] [Order article via Infotrieve]
15. Berridge, M. J. (1996) Biochem. J. 314, 1055-1056
16. Putney, J. W., and McKay, R. R. (1999) Bioessays 21, 38-46[CrossRef][Medline] [Order article via Infotrieve]
17. Elliott, A. C. (2001) Cell Calcium 30, 73-93[CrossRef][Medline] [Order article via Infotrieve]
18. Huber, A., Sander, P., Gobert, A., Bahner, M., Hermann, R., and Paulsen, R. (1996) EMBO J. 15, 7036-7045[Medline] [Order article via Infotrieve]
19. Birnbaumer, L., Zhu, X., Jiang, M. S., Boulay, G., Peyton, M., Vannier, B., Brown, D., Platano, D., Sadeghi, H., Stefani, E., and Birnbaumer, M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 15195-15202[Abstract/Free Full Text]
20. Lockwich, T., Liu, X., Singh, B., Jadlowiec, J., Weiland, S., and Ambbudkar, I. (2000) J. Biol. Chem. 275, 11934-11942[Abstract/Free Full Text]
21. Lee, H. C. (2001) Annu. Rev. Pharmacol. Toxicol. 41, 317-345[CrossRef][Medline] [Order article via Infotrieve]
22. Gaudry, M., Roberge, C. J., de Médicis, R., Lussier, A., Poubelle, P. E., and Naccache, P. H. (1993) J. Clin. Invest. 91, 1649-1655[Medline] [Order article via Infotrieve]
23. Grynkievicz, G., Poenie, M., and Tsien, R. Y. (1985) J. Biol. Chem. 260, 3440-3450[Abstract/Free Full Text]
24. Al-Shami, A., Gilbert, C., Barabé, F., Gaudry, M., and Naccache, P. H. (1997) J. Immunol. Methods 202, 183-191[CrossRef][Medline] [Order article via Infotrieve]
25. Marcil, J., Harbour, D., Houle, M. G., Naccache, P. H., and Bourgoin, S. (1999) Biochem. J. 337, 185-192[CrossRef][Medline] [Order article via Infotrieve]
26. Naccache, P. H., Bourgoin, S., Plante, E., Roberge, C. J., De, Médicis, R., Lussier, A., and Poubelle, P. E. (1993) Arthritis Rheum. 36, 117-125[Medline] [Order article via Infotrieve]
27. Bourgoin, S., Plante, E., Gaudry, M., Naccache, P. H., Borgeat, P., and Poubelle, P. E. (1990) J. Exp. Med. 172, 767-777[Abstract/Free Full Text]
28. Naccache, P. H., Gilbert, C., Caon, A. C., Gaudry, M., Huang, C. K., Bonak, V. A., Umezawa, K., and McColl, S. R. (1990) Blood 76, 2098-2104[Abstract/Free Full Text]
29. Kilsdonk, E. P., Yancey, P. G., Stoudt, G. W., Bangerter, F. W., Johnson, W. J., Phillips, M. C., and Rothblat, G. H. (1995) J. Biol. Chem. 270, 17250-17256[Abstract/Free Full Text]
30. Sheets, E. D., Holowka, D., and Baird, B. (1999) J. Cell Biol. 145, 877-887[Abstract/Free Full Text]
31. Petrie, R. J., Schnetkamp, P. P. M., Patel, K. D., AwasthiKalia, M., and Deans, J. P. (2000) J. Immunol. 165, 1220-1227[Abstract/Free Full Text]
32. Kabouridis, P. S., Janzen, J., Magee, A. L., and Ley, S. C. (2000) Eur. J. Immunol. 30, 954-963[CrossRef][Medline] [Order article via Infotrieve]
33. Schnitzer, J. E., Oh, P., Pinney, E., and Allard, J. (1994) J. Cell Biol. 127, 1217-1232[Abstract/Free Full Text]
34. Norman, A. W., Demel, R. A., de Kruyff, B., and van Deenen, L. L. (1972) J. Biol. Chem. 247, 1918-1929[Abstract/Free Full Text]
35. Bianchini, L., Todderud, G., and Grinstein, S. (1993) J. Biol. Chem. 268, 3357-3363[Abstract/Free Full Text]
36. Sage, S. O., Pintando, E., Mahaut-Smith, M. P., and Merritt, J. E. (1990) Biochem. J. 265, 915-918[Medline] [Order article via Infotrieve]
37. Naccache, P. H., Molski, T. F. P., Volpi, M., Becker, E. L., and Sha'afi, R. I. (1985) Biochem. Biophys. Res. Commun. 130, 677-684[CrossRef][Medline] [Order article via Infotrieve]
38. Naccache, P. H., Molski, M. M., Volpi, M., Shewfcyk, J., Molski, T. F. P., Loew, L., Becker, E. L., and Sha'afi, R. I. (1986) J. Leukocyte Biol. 40, 533-548[Abstract]
39. Foder, B., Scharff, O., and Thastrup, O. (1989) Cell Calcium 10, 477-490[CrossRef][Medline] [Order article via Infotrieve]
40. Wenzel-Seifert, K., Krautwurst, D., Musgrave, I., and Seifert, R. (1996) Biochem. J. 314, 679-686[Medline] [Order article via Infotrieve]
41. Czarny, M., Fiucci, G., Lavie, Y., Banno, Y., Nozawa, Y., and Liscovitch, M. (2000) FEBS Lett. 467, 326-332[CrossRef][Medline] [Order article via Infotrieve]
42. Davies, E. V., and Hallett, M. B. (1998) Int. J. Mol. Med. 1, 485-490[Medline] [Order article via Infotrieve]
43. Yamashita, T., Yamaguchi, T., Murakami, K., and Nagasawa, S. (2001) J. Biochem. (Tokyo) 129, 861-868[Abstract/Free Full Text]
44. Li, S. W., Okamoto, T., Chun, M. Y., Sargiacomo, M., Casanova, J. E., Hansen, S. H., Nishimoto, I., and Lisanti, M. P. (1995) J. Biol. Chem. 270, 15693-15701[Abstract/Free Full Text]
45. Brown, D. A., and London, E. (2000) J. Biol. Chem. 275, 17221-17224[Free Full Text]
46. Partida-Sanchez, S., Cockayne, D. A., Monard, S., Jacobson, E. L., Oppenheimer, N., Garvy, B., Kusser, K., Goodrich, S., Howard, M., Harmsen, A., Randall, T. D., and Lund, F. E. (2001) Nat. Med. 7, 1209-1216[CrossRef][Medline] [Order article via Infotrieve]
47. Zubiaur, M., Fernandez, O., Ferrero, E., Salmeron, J., Malissen, B., Malavasi, F., and Sancho, J. (2001) J. Biol. Chem. 31, 31
48. Bourgoin, S., and Grinstein, S. (1992) J. Biol. Chem. 267, 11908-11916[Abstract/Free Full Text]
49. Dewald, B., Thelen, M., and Baggiolini, M. (1988) J. Biol. Chem. 263, 16179-16184[Abstract/Free Full Text]
50. Kim, Y., Kim, J. E., Lee, S. D., Lee, T. G., Kim, J. H., Park, J. B., Han, J. M., Jang, S. K., Suh, P. G., and Ryu, S. H. (1999) Bba. Mol. Cell. Biol. Lipids 1436, 319-330
51. Kim, J. H., Han, J. M., Lee, S., Kim, Y., Lee, T. G., Park, J. B., Lee, S. D., Suh, P. G., and Ryu, S. H. (1999) Biochemistry U. S. A. 38, 3763-3769

Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
K. B. Kannan, D. Barlos, and C. J. Hauser
Free Cholesterol Alters Lipid Raft Structure and Function Regulating Neutrophil Ca2+ Entry and Respiratory Burst: Correlations with Calcium Channel Raft Trafficking
J. Immunol., April 15, 2007; 178(8): 5253 - 5261.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. G. Sitrin, S. L. Emery, T. M. Sassanella, R. A. Blackwood, and H. R. Petty
Selective Localization of Recognition Complexes for Leukotriene B4 and Formyl-Met-Leu-Phe within Lipid Raft Microdomains of Human Polymorphonuclear Neutrophils
J. Immunol., December 1, 2006; 177(11): 8177 - 8184.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
O. Diaz, S. Mebarek-Azzam, A. Benzaria, M. Dubois, M. Lagarde, G. Nemoz, and A.-F. Prigent
Disruption of Lipid Rafts Stimulates Phospholipase D Activity in Human Lymphocytes: Implication in the Regulation of Immune Function
J. Immunol., December 15, 2005; 175(12): 8077 - 8086.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
A. Ortiz-Stern and C. Rosales
Fc{gamma}RIIIB stimulation promotes {beta}1 integrin activation in human neutrophils
J. Leukoc. Biol., May 1, 2005; 77(5): 787 - 799.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. K. Mandal, A. Iakhiaev, U. R. Pendurthi, and L. V. M. Rao
Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol
Blood, January 1, 2005; 105(1): 153 - 160.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. B. Fessler, P. G. Arndt, S. C. Frasch, J. G. Lieber, C. A. Johnson, R. C. Murphy, J. A. Nick, D. L. Bratton, K. C. Malcolm, and G. S. Worthen
Lipid Rafts Regulate Lipopolysaccharide-induced Activation of Cdc42 and Inflammatory Functions of the Human Neutrophil
J. Biol. Chem., September 17, 2004; 279(38): 39989 - 39998.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. L. Kindzelskii, R. G. Sitrin, and H. R. Petty
Cutting Edge: Optical Microspectrophotometry Supports the Existence of Gel Phase Lipid Rafts at the Lamellipodium of Neutrophils: Apparent Role in Calcium Signaling
J. Immunol., April 15, 2004; 172(8): 4681 - 4685.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
R. G. Sitrin, D. R. Johnson, P. M. Pan, D. M. Harsh, J. Huang, H. R. Petty, and R. A. Blackwood
Lipid Raft Compartmentalization of Urokinase Receptor Signaling in Human Neutrophils
Am. J. Respir. Cell Mol. Biol., February 1, 2004; 30(2): 233 - 241.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Li, L. M. Ayer, J. Lytton, and J. P. Deans
Store-operated Cation Entry Mediated by CD20 in Membrane Rafts
J. Biol. Chem., October 24, 2003; 278(43): 42427 - 42434.
[Abstract] [Full Text] [PDF]